Biolife Solutions (BLFS) Payables (2010 - 2026)

Biolife Solutions (BLFS) has reported Payables for 17 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 22.66% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 22.66% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 55.77% from the prior year.
• Payables was $2.5 million for Q2 2026 at Biolife Solutions, down from $3.8 million in the prior quarter.
• Over five years, Payables peaked at $15.5 million in Q1 2023 and troughed at $1.5 million in Q4 2025.
• A 5-year average of $7.0 million and a median of $4.0 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables surged 173.88% in 2022 and sank 85.23% in 2023, its largest moves.
• Over 5 years, Payables stood at $15.4 million in 2022, then tumbled by 85.23% to $2.3 million in 2023, then soared by 48.02% to $3.4 million in 2024, then plunged by 55.77% to $1.5 million in 2025, then soared by 67.03% to $2.5 million in 2026.
• The last three Payables figures came in at $2.5 million (Q2 2026), $3.8 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.